Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Luspatercept for Anemia Following Allo-HSCT in Acute Leukemia
NCT07362095Phase 2Recruiting
- Sponsor
- Southern Medical University Zhujiang Hospital
- Start
- Oct 2025
- Primary completion
- Dec 2027
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of luspatercept in anemia, sponsored by Southern Medical University Zhujiang Hospital. Started Oct 2025; status: recruiting.
02
Drugs
luspatercept
03
Conditions
anemia
Beyond the preview
Go deeper on NCT07362095.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07362095.